Actemra - Local Bosnian Open, Multicentric, Trial to Evaluate Safety, Tolerability and Efficacy of Tocilizumab in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis After Inadequate Response to DMARDs.
Phase of Trial: Phase III
Latest Information Update: 27 Nov 2014
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Registrational
- Acronyms ALABASTER
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 14 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jul 2012 Actual patient number changed from 69 to 71 as reported by ClinicalTrials.gov.